Cardiac hormones are inhibitors of Wnt-3a in human cancer cells

Cancer Therapy

Volumn 9, Issue , 2013, Pages 24-29

  Skelton IV, W P ^a,b   Skelton, M ^a   Vesely, David L ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Colorectal adenocarcinomas; Natriuretic peptides; Pancreatic carcinomas; Renal adenocarcinoma

Indexed keywords

ATRIAL NATRIURETIC FACTOR; KALIURETIC PEPTIDE; LONG ACTING NATRIURETIC PEPTIDE; PEPTIDE HORMONE; UNCLASSIFIED DRUG; VESSEL DILATOR; WNT3A PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PANCREAS CARCINOMA; WNT SIGNALING PATHWAY;

EID: 84875885225     PISSN: 15439135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Amaravadi R and Thompson CB (2005) The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 115: 2618-2624.
2. Bienz M and Clevers H (2000) Linking colorectal cancer to Wnt signaling. Cell 103: 311-320.
3. Daggubati S, Parks JR, Overton RM, Cintron G, Shocken DD, and Vesely DL (1997) Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators. Cardiovascular Res 36: 246-255.
4. Derijard R, Hibi M, Wu IH, Barrett T, Su B, Deng TL, Karin M, and Davis RJ (1994) Jnk1-a protein kinase stimulated by UV-light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037.
5. Eichelbaum EJ, Sun Y, Alli AA, Gower Jr WR, and Vesely DL. (2008) Cardiac hormones and urodilatin eliminate up to 86% of human small-cell lung carcinomas in mice. Eur J Clin Invest 38: 562-570.
6. Gower WR Jr, Vesely BA, Alli AA, and Vesely DL. (2005) Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via guanosine 3',5'-cyclic monophosphate. Int J Gastrointestinal Cancer 36: 77-87.
7. Katoh M. (2002) Regulation of WNT3 and WNT3A mRNAs in human cancer cell lines NT2, MCF-7, and MKN45. Int J Oncol 20: 373-377.
8. Lane ML, Santana O, Frost CD, Nguyen J, Guerrero J, Skelton WP IV, Skelton M, and Vesely DL. (2012) Cardiac hormones are c-Jun-N-Terminal Kinase 2-inhibiting peptides. Anticancer Res 32: 721-726.
9. Li J, Mizukami Y, Zhang X, Jo W-S, and Chung DC. (2005) Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3beta. Gastroenterology 128: 1907-1918.
10. Nguyen JP, Frost CD, Lane ML, Skelton WP IV, Skelton M, and Vesely DL. (2012) Novel dual inhibitors of vascular endothelial growth factor and the VEGFR2 receptor. Eur J Clin Invest 42: 1061-1067.
11. Okada F, Rak JW, Croix BS, Lieubeau B, Kaya M, Roncari L, Shirasawa S, Sasazuki T, and Kerbel RS. (1998) Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc Natl Acad Sci USA 95: 3609-3614.
12. Polakis P. (2012) Drugging Wnt signaling in cancer. EMBO J 31: 2737-2746.
13. Serafino A, Moroni N, Psaila R, Zonfrillo M, Andreola F, Wannenes F, Mercuri L, Rasi G, and Pierimarchi P. (2012) Anti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: evidence for an Akt-mediated cross-talk between acidic tumor microenvironment and Wnt/beta-catenin signaling. Biochim Biophys Acta 1822: 1004-1018.
14. Siegel R, Naishadham D, and Jemal A. (2012) Cancer Statistics. CA Cancer J Clin 62: 10-29.
15. Skelton WP, IV, Pi GE, and Vesely DL (2012) Four cardiac hormones cause death of human cancer cells but not of healthy cells. Anticancer Res 31: 395-402.
16. Sun Y, Eichelbaum EJ, Wang H, and Vesely DL. (2006a) Vessel dilator and kaliuretic peptide inhibit activation of ERK 1/2 in human prostate cancer cells. Anticancer Res 26: 3217-3222.
17. Sun Y, Eichelbaum EJ, Wang H, and Vesely DL. (2007a) Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells. Anticancer Res 27: 1387-1392.
18. Sun Y, Eichelbaum EJ, Wang H, and Vesely DL. (2006b) Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells. Anticancer Res 26: 4143-4148.
19. Sun Y, Eichelbaum EJ, Wang H, and Vesely DL. (2007b) Atrial natriuretic peptide and long acting atrial natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells. Anticancer Res 27: 3813-3818.
20. Sun Y, Eichelbaum EJ, Lenz A, Skelton WP IV, Wang H, and Vesely DL. (2009a) Atrial natriuretic peptide and long acting natriuretic peptide inhibit Ras in human prostate cancer cells. Anticancer Res 29: 1889-1893.
21. Sun Y, Eichelbaum EJ, Skelton WP IV, Lenz A, Regales N, Wang H, and Vesely DL.(2009b) Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells. Anticancer Res 29: 971-975.
22. Vesely BA, McAfee Q, Gower WR Jr, and Vesely DL. (2003) Four peptides decrease the number of human pancreatic adenocarcinoma cells. Eur J Clin Invest 33: 998-1005.
23. Vesely BA, Alli AA, Song S, Gower WR Jr, Sanchez-Ramos J, and Vesely DL. (2005a) Four peptide hormones specific decrease (up to 97%) of human prostate carcinoma cells. Eur J Clin Invest 35: 700-710.
24. Vesely BA, Song S, Sanchez-Ramos J, Fitz SR, Alli A, Solivan SM, Gower WR Jr, and Vesely DL. (2005b) Five cardiac hormones decrease the number of human small-cell cancer cells. Eur J Clin Invest 35: 388-398.
25. Vesely BA, Song S, Sanchez-Ramos J, Fitz SR, Solivan SM, Gower WR Jr, and Vesely DL. (2005c) Four peptide hormones decrease the number of human breast adenocarcinoma cells. Eur J Clin Invest 35: 60-69.
26. Vesely BA, Eichelbaum EJ, Alli AA, Sun Y, Gower WR Jr, and Vesely DL. (2006a) Urodilatin and four cardiac hormones decrease human renal carcinoma cell number. Eur J Clin Invest 36: 810-819.
27. Vesely BA, Fitz SR, Gower WR Jr, and Vesely DL. (2006b) Vessel dilator: Most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of squamous lung cancer cells. Cancer Lett 232: 226-231.
28. Vesely BA, Eichelbaum EJ, Alli AA, Sun Y, Gower WR Jr, and Vesely DL. (2007) Four cardiac hormones cause cell death in 81% of human ovarian adenocarcinoma cells. Cancer Therapy 5: 97-104.
29. Vesely DL, Eichelbaum EJ, Sun Y, Alli AA, Vesely BA, Luther SL, and Gower WR Jr. (2007a) Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones. In Vivo 21: 445-452.
30. Vesely DL, Vesely BA, Eichelbaum EJ, Sun Y, Alli AA, and Gower WR Jr. (2007b) Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice. In Vivo 21: 973-978.
31. Zhang X, Gaspard JP, and Chung DC. (2001) Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 61: 6050-6054.